Part-time Versus Full-time Spectacles for Myopia Control (ParMA Study)
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose is to assess the effect of part-time compared to full-time spectacle use in juvenile myopia control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2019
CompletedFirst Submitted
Initial submission to the registry
April 18, 2021
CompletedFirst Posted
Study publicly available on registry
April 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 25, 2021
CompletedDecember 22, 2021
December 1, 2021
1.6 years
April 18, 2021
December 7, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in spherical equivalent refractive error (SER), measured using cycloplegic autorefraction.
Baseline to 6-months, and baseline to 12-months.
Change in axial length (AL).
Baseline to 6-months, and baseline to 12-months.
Secondary Outcomes (2)
Change in choroidal thickness (ChT).
Baseline to 6-months, and baseline to 12-months.
Subjective tolerance, as assessed using a standardized questionnaire created for the purpose of this study.
Baseline to 12-months.
Study Arms (2)
Study Group
EXPERIMENTALPart-time myopia correction with single-vision spectacles
Control Group
ACTIVE COMPARATORFull-time myopia correction with single-vision spectacles
Interventions
Eligibility Criteria
You may qualify if:
- Age 4 to 16 years old at the time of enrollment.
- Best-corrected visual acuity (BCVA) LogMAR 0.1 or better, in each eye.
- Cycloplegic Autorefraction: Myopia, SER between -0.50D and -6.00D, in each eye. Astigmatism less than or equal to 1.50D, in each eye. Anisometropia less than or equal to 1.50D between the two eyes.
- Absence of any ocular or systemic condition that could influence refractive development, other than myopia.
- Eagerness to participate in this study and receive myopia treatment in a randomized fashion. Availability for at least 1-year follow-up. Subject parent's or guardian's understanding of the protocol and acceptance to participate, providing a signed consent on behalf of the subject.
You may not qualify if:
- Presence of strabismus.
- Presence of amblyopia.
- Prematurity (gestational age less than 37 weeks).
- Presence of an ocular condition affecting refraction (ie. cataract, dislocated lens).
- Presence of a systemic condition affecting refraction (ie. Down syndrome, Marfan syndrome).
- Allergy to cyclopentolate. Severe ocular or systemic allergies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
"Papageorgiou" General Hospital
Thessaloniki, 56429, Greece
Related Publications (3)
Vasudevan B, Esposito C, Peterson C, Coronado C, Ciuffreda KJ. Under-correction of human myopia--is it myopigenic?: a retrospective analysis of clinical refraction data. J Optom. 2014 Jul-Sep;7(3):147-52. doi: 10.1016/j.optom.2013.12.007. Epub 2014 May 10.
PMID: 25000870BACKGROUNDSun YY, Li SM, Li SY, Kang MT, Liu LR, Meng B, Zhang FJ, Millodot M, Wang N. Effect of uncorrection versus full correction on myopia progression in 12-year-old children. Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):189-195. doi: 10.1007/s00417-016-3529-1. Epub 2016 Oct 29.
PMID: 27796670BACKGROUNDLogan NS, Wolffsohn JS. Role of un-correction, under-correction and over-correction of myopia as a strategy for slowing myopic progression. Clin Exp Optom. 2020 Mar;103(2):133-137. doi: 10.1111/cxo.12978. Epub 2019 Dec 18.
PMID: 31854025BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor in Ophthalmology, Paediatric Ophthalmology and Strabismus
Study Record Dates
First Submitted
April 18, 2021
First Posted
April 22, 2021
Study Start
November 15, 2019
Primary Completion
June 28, 2021
Study Completion
November 25, 2021
Last Updated
December 22, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share